Sonographically guided core biopsy

Journal of Ultrasound in Medicine

Volumn 32, Issue 11, 2013, Pages 2023-2027

  Oge, Tufan ^a   Yalcin, Omer T ^a   Ozalp, S Sinan ^a   Kebapci, Mahmut ^a   Aydin, Yunus ^a   Telli, Elcin ^a  

^a OSMANGAZI UNIVERSITY MEDICAL FACULTY   (Turkey)

Author keywords

Advanced ovarian cancer; Core biopsy; Neoadjuvant chemotherapy; Peritoneal tuberculosis; Sonographically guided biopsy

Indexed keywords

CHEMOTHERAPY; DISEASES; ONCOLOGY; TUMORS;

COLORECTAL CANCER; CORE BIOPSY; DIFFERENTIAL DIAGNOSIS; MINIMALLY INVASIVE; NEOADJUVANT CHEMOTHERAPIES; OVARIAN CANCERS; PERITONEAL TUBERCULOSIS; POOR PERFORMANCE;

BIOPSY;

ADJUVANT CHEMOTHERAPY; ADNEXA DISEASE; ADVANCED OVARIAN CANCER; ARTICLE; CORE BIOPSY; ECHOGRAPHY; ENDOSCOPIC ECHOGRAPHY; FEMALE; HUMAN; IMAGE GUIDED BIOPSY; LARGE CORE NEEDLE BIOPSY; METHODOLOGY; MIDDLE AGED; OVARY TUMOR; PATHOLOGY; REPRODUCIBILITY; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SONOGRAPHICALLY GUIDED BIOPSY; TUBERCULOUS PERITONITIS; UTERUS CANCER;

ADVANCED OVARIAN CANCER; CORE BIOPSY; NEOADJUVANT CHEMOTHERAPY; PERITONEAL TUBERCULOSIS; SONOGRAPHICALLY GUIDED BIOPSY;

ADNEXAL DISEASES; BIOPSY, LARGE-CORE NEEDLE; FEMALE; HUMANS; IMAGE-GUIDED BIOPSY; MIDDLE AGED; OVARIAN NEOPLASMS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, INTERVENTIONAL; UTERINE NEOPLASMS;

EID: 84887215912     PISSN: 02784297     EISSN: 15509613     Source Type: Journal    
DOI: 10.7863/ultra.32.11.2023     Document Type: Article

References (22)

1. Zikan M, Fischerova D, Pinkavova I, Dundr P, Cibula D. Ultrasonographic appearance of metastatic non-gynecological pelvic tumors. Ultrasound Obstet Gynecol 2012; 39:215-225
2. Heatley MK. A systematic review of papers examining the use of intraoperative frozen section in predicting the final diagnosis of ovarian lesions. Int J Gynecol Pathol 2012; 31:111-115
3. Griffiths CT, Fuller AF. Intensive surgical and chemotherapeutic management of advanced ovarian cancer. Surg Clin North Am 1978; 58:131-142
4. Polterauer S, Vergote I, Concin N, et al. Prognostic value of residual tumor size in patients with epithelial ovarian cancer FIGO stages 2A-4: analysis of the OVCAD data. Int J Gynecol Cancer 2012; 22:380-385
5. Vergote I, van Gorp T, Amant F, Leunen K, Neven P, Berteloot P. Timing of debulking surgery in advanced ovarian cancer. Int J Gynecol Cancer 2008; 18:11-19
6. Oge T, Zeck W, Tamussino K. An adenocarcinoid tumour of the appendix mimicking advanced ovarian carcinoma. J Obstet Gynaecol 2009; 29:780-781
7. Ayhan A, Guvenal T, Salman MC, Ozyuncu O, Sakinci M, Basaran M. The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries. Gynecol Oncol 2005; 98:235-241
8. Woodcock NP, Glaves I, Morgan DR, MacFie J. Ultrasound-guided Tru-Cut biopsy of the breast. Ann R Coll Surg Engl 1998; 80:253-256
9. Chopra S, Rowe EW, Laniado M, Patel A. A prospective study analysing the effect of pain on probe insertion, and the biopsy strategy, on the patients' perception of pain during TRUS-guided biopsy of the prostate. NZ Med J 2008; 121:39-43
10. Fischerova D, Cibula D, Dundr P, et al. Ultrasound-guided tru-cut biopsy in the management of advanced abdomino-pelvic tumors. Int J Gynecol Cancer 2008; 18:833-837
11. Zikan M, Fischerova D, Pinkavova I, Dundr P, Cibula D. Ultrasoundguided tru-cut biopsy of abdominal and pelvic tumors in gynecology. Ultrasound Obstet Gynecol 2010; 36:767-772
12. Oken MM, Creech RH, Tormey DC, et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5:649-655
13. Kebapci M, Akca AK, Yalcin OT, Ozalp SS, Calisir C, Mutlu F. Prediction of suboptimal cytoreduction of epithelial ovarian carcinoma by preoperative computed tomography. Eur J Gynaecol Oncol 2010; 31:44-49
14. Freedman OC, Dodge J, Shaw P, et al. Diagnosis of epithelial ovarian carcinoma prior to neoadjuvant chemotherapy. Gynecol Oncol 2010; 119:22-25
15. Bandyopadhyay A, Chakraborty J, Chowdhury AR, Bhattacharya A, Bhattachrya P, Chowdhury M. Fine needle aspiration cytology of ovarian tumors with histological correlation. J Cytol 2012; 29:35-40
16. Chojniak R, Isberner RK, Viana LM, Yu LS, Aita AA, Soares FA. Computed tomography guided needle biopsy: experience from 1300 procedures. Sao Paulo Med J 2006; 124:10-14
17. Oge T, Ozalp SS, Yalcin OT, et al. Peritoneal tuberculosis mimicking ovarian cancer. Eur J Obstet Gynecol Reprod Biol 2012; 162:105-108
18. du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J. Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO). Cancer 2009; 115:1234-1244
19. Chi DS, Bristow RE, Armstrong DK, Karlan BY. Is the easier way ever the better way? J Clin Oncol 2011; 29:4073-4075
20. Bristow RE, Eisenhauer EL, Santillan A, Chi DS. Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction. Gynecol Oncol 2007; 104:480-490
21. Vergote I, Tropé CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in stage 3C or 4 ovarian cancer. N Engl J Med 2010; 363:943-953
22. Vergote I, Amant F, Leunen K. Neoadjuvant chemotherapy in advanced ovarian cancer: what kind of evidence is needed to convince US gynaecological oncologists? Gynecol Oncol 2010; 119:1-2